Suppr超能文献

血管紧张素II受体阻断可降低心动过速诱导的心房黏附分子表达。

Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression.

作者信息

Goette Andreas, Bukowska Alicja, Lendeckel Uwe, Erxleben Michaela, Hammwöhner Matthias, Strugala Denis, Pfeiffenberger Jan, Röhl Friedrich-Wilhelm, Huth Christof, Ebert Matthias P A, Klein Helmut U, Röcken Christoph

机构信息

Division of Cardiology, Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany.

出版信息

Circulation. 2008 Feb 12;117(6):732-42. doi: 10.1161/CIRCULATIONAHA.107.730101. Epub 2008 Jan 28.

Abstract

BACKGROUND

Increased levels of inflammatory markers are predictors of thromboembolic events during atrial fibrillation (AF). Increased endocardial expression of adhesion molecules (ie, vascular cell adhesion molecule [VCAM] and intercellular adhesion molecule [ICAM]) could be an important link between initiation of inflammatory and prothrombogenic mechanisms responsible for thrombus development at the atrial endocardium (endocardial remodeling).

METHODS AND RESULTS

Tissue microarrays were used to screen right atrial tissue specimens obtained from 320 consecutive patients for differences in atrial expression of the prothrombogenic proteins VCAM-1, ICAM-1, thrombomodulin, plasminogen activator inhibitor-1, and von Willebrand factor. An in vitro organotypic human atrial tissue model and a pig model of rapid atrial pacing were used to determine the therapeutic impact of angiotensin II receptor blockade. Immunohistochemical analyses showed that all prothrombogenic proteins are expressed by endocardial cells. Using multivariable analysis, only the intensity of VCAM-1 expression was increased in patients with AF (P=0.03). Increased atrial VCAM-1 expression was confirmed by Western blotting in patients with persistent and paroxysmal AF (persistent AF 207+/-42% versus sinus rhythm 100+/-16%, P=0.028; paroxysmal AF 193+/-42%, P=0.024 versus sinus rhythm). In vitro pacing of ex vivo human atrial tissue slices confirmed that rapid activation causes VCAM-1 upregulation (mRNA and protein levels). Pacing-induced VCAM-1 expression was abolished by olmesartan. To confirm this finding in vivo, VCAM-1 expression was determined in 14 pigs after rapid atrial pacing (600 bpm). Atrial tachycardia caused an upregulation of VCAM-1 expression, which was prevented by irbesartan, consistent with the observed increase in plasma levels of angiotensin II. Alterations in the in vivo VCAM-1 expression were more pronounced in the left atrium (>5-fold compared with sham) than in the right atrium (3.5-fold compared with sham).

CONCLUSIONS

AF and rapid atrial pacing both increase endocardial VCAM-1 expression, which can be attenuated by angiotensin II receptor blockade. This provides evidence that angiotensin II plays a pathophysiological role in prothrombotic endocardial remodeling.

摘要

背景

炎症标志物水平升高是心房颤动(AF)期间血栓栓塞事件的预测指标。黏附分子(即血管细胞黏附分子[VCAM]和细胞间黏附分子[ICAM])的心内膜表达增加可能是引发炎症和促血栓形成机制之间的重要联系,这些机制导致心房心内膜血栓形成(心内膜重塑)。

方法与结果

使用组织微阵列筛选从320例连续患者获得的右心房组织标本,以检测促血栓形成蛋白VCAM-1、ICAM-1、血栓调节蛋白、纤溶酶原激活物抑制剂-1和血管性血友病因子在心房表达的差异。使用体外器官型人心房组织模型和快速心房起搏猪模型来确定血管紧张素II受体阻滞剂的治疗效果。免疫组织化学分析表明,所有促血栓形成蛋白均由心内膜细胞表达。通过多变量分析,仅AF患者的VCAM-1表达强度增加(P=0.03)。持续性和阵发性AF患者经蛋白质印迹法证实心房VCAM-1表达增加(持续性AF为207±42%,窦性心律为100±16%,P=0.028;阵发性AF为193±42%,与窦性心律相比,P=0.024)。体外对离体人心房组织切片进行起搏证实,快速激活会导致VCAM-1上调(mRNA和蛋白质水平)。奥美沙坦可消除起搏诱导的VCAM-1表达。为在体内证实这一发现,对14头快速心房起搏(600次/分钟)后的猪测定VCAM-1表达。房性心动过速导致VCAM-1表达上调,厄贝沙坦可预防这种上调,这与观察到的血浆血管紧张素II水平升高一致。体内VCAM-1表达的改变在左心房(与假手术组相比增加>5倍)比右心房(与假手术组相比增加3.5倍)更明显。

结论

AF和快速心房起搏均会增加心内膜VCAM-1表达,血管紧张素II受体阻滞剂可使其减弱。这提供了证据表明血管紧张素II在促血栓形成的心内膜重塑中起病理生理作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验